CRIS Current Research Information System

BARTOLETTI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.299
EU - Europa 4.583
AS - Asia 4.282
AF - Africa 353
SA - Sud America 323
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.863
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.237
SG - Singapore 1.381
CN - Cina 1.130
GB - Regno Unito 1.094
IT - Italia 912
VN - Vietnam 811
SE - Svezia 707
DE - Germania 562
HK - Hong Kong 365
IN - India 255
RU - Federazione Russa 229
BR - Brasile 218
IE - Irlanda 198
FR - Francia 173
CI - Costa d'Avorio 134
NL - Olanda 121
BG - Bulgaria 111
KR - Corea 105
CH - Svizzera 76
TG - Togo 73
ZA - Sudafrica 65
FI - Finlandia 63
JO - Giordania 56
UA - Ucraina 56
AT - Austria 48
ES - Italia 48
EE - Estonia 47
ID - Indonesia 43
BE - Belgio 42
AR - Argentina 41
CA - Canada 35
JP - Giappone 32
NG - Nigeria 31
SC - Seychelles 19
EC - Ecuador 18
PL - Polonia 18
IR - Iran 17
MX - Messico 15
AU - Australia 14
CO - Colombia 14
BD - Bangladesh 12
RO - Romania 11
HR - Croazia 10
LT - Lituania 10
GR - Grecia 9
CL - Cile 8
MY - Malesia 8
PY - Paraguay 8
PK - Pakistan 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
PH - Filippine 6
TR - Turchia 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
AZ - Azerbaigian 4
HN - Honduras 4
IL - Israele 4
KZ - Kazakistan 4
MA - Marocco 4
PA - Panama 4
PT - Portogallo 4
UY - Uruguay 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
EG - Egitto 3
LB - Libano 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SA - Arabia Saudita 3
VE - Venezuela 3
BO - Bolivia 2
EU - Europa 2
HU - Ungheria 2
LU - Lussemburgo 2
LY - Libia 2
MN - Mongolia 2
SM - San Marino 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GY - Guiana 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 15.847
Salva come PNG Salva come JPEG
Città #
Southend 999
Singapore 990
Ashburn 758
Chandler 634
Fairfield 596
Hong Kong 360
Santa Clara 292
Woodbridge 267
Wilmington 266
Houston 253
Seattle 241
Ann Arbor 227
Princeton 215
Cambridge 211
Dong Ket 206
Bologna 205
Dublin 197
Beijing 185
Hefei 181
Ho Chi Minh City 149
Boardman 143
Abidjan 134
New York 108
Sofia 108
Los Angeles 97
Hanoi 96
Seoul 95
Lomé 73
Berlin 65
Bern 62
Milan 62
Nanjing 61
Westminster 60
Amman 56
Redmond 55
Bremen 53
Dallas 50
Padova 44
Redondo Beach 44
San Diego 42
Brussels 40
Saint Petersburg 40
Helsinki 37
Buffalo 36
Jinan 36
Munich 35
Turin 35
Shanghai 34
Falls Church 33
Frankfurt am Main 33
Rome 33
Chicago 31
Jakarta 31
Florence 30
Abeokuta 27
Redwood City 27
Shenyang 27
São Paulo 27
Des Moines 25
London 25
Amsterdam 24
Tokyo 24
Vienna 24
Guangzhou 22
Lappeenranta 22
Nuremberg 22
Hebei 21
Changsha 20
Nanchang 20
Olalla 20
Verona 20
Bengaluru 19
Bühl 18
Dearborn 17
Toronto 17
Ningbo 16
Phoenix 16
San Francisco 16
Washington 16
Zhengzhou 15
Da Nang 14
Paris 13
Brooklyn 12
Falkenstein 12
Haikou 12
Jiaxing 12
Hải Dương 11
Quito 11
Denver 10
Haiphong 10
Hangzhou 10
Leganés 10
Moscow 10
Parma 10
Quận Bình Thạnh 9
Stockholm 9
Tampa 9
Council Bluffs 8
Duncan 8
Medford 8
Totale 10.179
Salva come PNG Salva come JPEG
Nome #
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 540
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 290
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 283
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 233
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 221
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 208
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 204
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 203
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 198
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 197
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 194
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 184
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 184
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 183
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 178
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 177
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 177
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 177
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 173
Characterization of antibody response in neuroinvasive infection caused by Toscana virus 172
Advances in the therapy of bacterial bloodstream infections 169
Bloodstream infections in patients with liver cirrhosis 167
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 167
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 165
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 162
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 161
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 160
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 158
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 157
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 157
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 157
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 157
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 155
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 154
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 153
Classification performance for covid patient prognosis from automatic ai segmentation—a single-center study 153
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 150
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 149
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 149
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 145
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 144
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 144
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 143
null 142
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 140
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 139
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 139
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 139
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) 138
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 138
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 138
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 135
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors. 134
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 134
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 134
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 134
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis 132
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis 132
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 131
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 130
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 130
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 128
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 128
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 126
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 126
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 126
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 119
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study 119
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 118
Outcome Prediction for SARS-CoV-2 Patients Using Machine Learning Modeling of Clinical, Radiological, and Radiomic Features Derived from Chest CT Images 115
The Gut Microbiota of Critically Ill Patients With COVID-19 114
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 113
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 113
ESCMID COVID-19 living guidelines: drug treatment and clinical management 112
Opportunistic infections in end stage liver disease 111
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 110
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study 110
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 109
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 108
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 107
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 106
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 106
Use of critical care resources during the first 2 weeks (February 24-March 8, 2020) of the Covid-19 outbreak in Italy 106
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 104
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort 104
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 103
Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain 103
null 102
Procalcitonin-guided antibiotic therapy: An expert consensus 99
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation 98
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 97
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 94
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients 93
null 91
null 90
Genetic and Functional Characterization of Toll-Like Receptor Responses in Immunocompetent Patients With CMV Mononucleosis 90
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 89
null 88
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 86
How do I manage a patient with enterococcal bacteraemia? 85
Totale 14.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.955
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.152 0 0 0 0 0 75 65 130 155 133 97 497
2021/20222.508 182 78 98 203 170 136 105 214 134 296 472 420
2022/20232.729 251 324 150 362 210 209 84 203 489 122 183 142
2023/20241.039 66 149 62 101 72 230 66 79 43 79 52 40
2024/20252.880 146 384 236 259 432 169 230 97 58 190 151 528
2025/20262.978 619 567 524 470 746 52 0 0 0 0 0 0
Totale 16.304